Literature DB >> 31342451

Validation and Comparison of Noncontrast CT Scores to Predict Intracerebral Hemorrhage Expansion.

Loris Poli1, Eleonora Leuci2, Paolo Costa3, Valeria De Giuli4, Filomena Caria4, Elisa Candeloro2, Alessandra Persico2, Massimo Gamba5, Mauro Magoni5, Giuseppe Micieli6, Anna Cavallini2, Alessandro Padovani4, Alessandro Pezzini4, Andrea Morotti2.   

Abstract

BACKGROUND AND
PURPOSE: The BAT, BRAIN, and HEP scores have been proposed to predict hematoma expansion (HE) with noncontrast computed tomography (NCCT). We sought to validate these tools and compare their diagnostic performance.
METHODS: We retrospectively analyzed two cohorts of patients with primary intracerebral hemorrhage. HE expansion was defined as volume growth > 33% or > 6 mL. Two raters analyzed NCCT scans and calculated the scores, blinded to clinical and imaging data. The inter-rater reliability was assessed with the interclass correlation statistic. Discrimination and calibration were calculated with area under the curve (AUC) and Hosmer-Lemeshow χ2 statistic, respectively. AUC comparison between different scores was explored with DeLong test. We also calculated the sensitivity, specificity, positive, and negative predictive values of the dichotomized scores with cutoffs identified with the Youden's index.
RESULTS: A total of 230 subjects were included, of whom 86 (37.4%) experienced HE. The observed AUC for HE were 0.696 for BAT, 0.700 for BRAIN, and 0.648 for HEP. None of the scores had a significantly superior AUC compared with the others (all p > 0.4). All the scores had good calibration (all p > 0.3) and good-to-excellent inter-rater reliability (interclass correlation > 0.8). BAT ≥ 3 showed the highest specificity (0.81), whereas BRAIN ≥ 6 had the highest sensitivity (0.76).
CONCLUSIONS: The BAT, BRAIN, and HEP scores can predict HE with acceptable discrimination and require just a baseline NCCT scan. These tools may be used to stratify the risk of HE in clinical practice or randomized controlled trials.

Entities:  

Keywords:  BAT; BRAIN; HEP; Hematoma expansion; Intracerebral hemorrhage; STROKE; Score

Mesh:

Year:  2020        PMID: 31342451     DOI: 10.1007/s12028-019-00797-2

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  34 in total

1.  Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study.

Authors:  Andrew M Demchuk; Dar Dowlatshahi; David Rodriguez-Luna; Carlos A Molina; Yolanda Silva Blas; Imanuel Dzialowski; Adam Kobayashi; Jean-Martin Boulanger; Cheemun Lum; Gord Gubitz; Vasantha Padma; Jayanta Roy; Carlos S Kase; Jayme Kosior; Rohit Bhatia; Sarah Tymchuk; Suresh Subramaniam; David J Gladstone; Michael D Hill; Richard I Aviv
Journal:  Lancet Neurol       Date:  2012-03-08       Impact factor: 44.182

2.  Prospective validation of the computed tomographic angiography spot sign score for intracerebral hemorrhage.

Authors:  Javier M Romero; H Bart Brouwers; Jingjing Lu; Josser E Delgado Almandoz; Hillary Kelly; Jeremy Heit; Joshua Goldstein; Jonathan Rosand; R Gilberto Gonzalez
Journal:  Stroke       Date:  2013-09-10       Impact factor: 7.914

Review 3.  Options to restrict hematoma expansion after spontaneous intracerebral hemorrhage.

Authors:  Thorsten Steiner; Julian Bösel
Journal:  Stroke       Date:  2009-12-31       Impact factor: 7.914

4.  Intensive Blood Pressure Reduction and Spot Sign in Intracerebral Hemorrhage: A Secondary Analysis of a Randomized Clinical Trial.

Authors:  Andrea Morotti; H Bart Brouwers; Javier M Romero; Michael J Jessel; Anastasia Vashkevich; Kristin Schwab; Mohammad Rauf Afzal; Christy Cassarly; Steven M Greenberg; Renee Hebert Martin; Adnan I Qureshi; Jonathan Rosand; Joshua N Goldstein
Journal:  JAMA Neurol       Date:  2017-08-01       Impact factor: 18.302

Review 5.  Diagnosis and Management of Acute Intracerebral Hemorrhage.

Authors:  Andrea Morotti; Joshua N Goldstein
Journal:  Emerg Med Clin North Am       Date:  2016-09-03       Impact factor: 2.264

Review 6.  Noncontrast Computed Tomography Markers of Intracerebral Hemorrhage Expansion.

Authors:  Gregoire Boulouis; Andrea Morotti; Andreas Charidimou; Dar Dowlatshahi; Joshua N Goldstein
Journal:  Stroke       Date:  2017-03-13       Impact factor: 7.914

7.  Predicting hematoma expansion after primary intracerebral hemorrhage.

Authors:  H Bart Brouwers; Yuchiao Chang; Guido J Falcone; Xuemei Cai; Alison M Ayres; Thomas W K Battey; Anastasia Vashkevich; Kristen A McNamara; Valerie Valant; Kristin Schwab; Susannah C Orzell; Linda M Bresette; Steven K Feske; Natalia S Rost; Javier M Romero; Anand Viswanathan; Sherry H-Y Chou; Steven M Greenberg; Jonathan Rosand; Joshua N Goldstein
Journal:  JAMA Neurol       Date:  2014-02       Impact factor: 18.302

Review 8.  Intracerebral haemorrhage.

Authors:  Adnan I Qureshi; A David Mendelow; Daniel F Hanley
Journal:  Lancet       Date:  2009-05-09       Impact factor: 79.321

9.  Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes.

Authors:  D Dowlatshahi; A M Demchuk; M L Flaherty; M Ali; P L Lyden; E E Smith
Journal:  Neurology       Date:  2011-02-23       Impact factor: 9.910

10.  Clinical prediction algorithm (BRAIN) to determine risk of hematoma growth in acute intracerebral hemorrhage.

Authors:  Xia Wang; Hisatomi Arima; Rustam Al-Shahi Salman; Mark Woodward; Emma Heeley; Christian Stapf; Pablo M Lavados; Thompson Robinson; Yining Huang; Jiguang Wang; Candice Delcourt; Craig S Anderson
Journal:  Stroke       Date:  2014-12-11       Impact factor: 7.914

View more
  6 in total

1.  Hematoma Ventricle Distance on Computed Tomography Predicts Poor Outcome in Intracerebral Hemorrhage.

Authors:  Lan Deng; Yun-Dong Zhang; Jian-Wen Ji; Wen-Song Yang; Xiao Wei; Yi-Qing Shen; Rui Li; Shu-Qiang Zhang; Xin-Ni Lv; Xin-Hui Li; Zhou-Ping Tang; Guo-Feng Wu; Li-Bo Zhao; Peng Xie; Qi Li
Journal:  Front Neurosci       Date:  2020-11-19       Impact factor: 4.677

2.  Association Between Anatomical Location and Hematoma Expansion in Deep Intracerebral Hemorrhage.

Authors:  Lei Song; Xiao-Ming Qiu; Ting-Ting Guo; Hang Zhou; Dong-Fang Tang; Long-Sheng Wang; Yu-Fei Fu; Hui Chen; Hua-Qing Mao; Hai-Bao Wang; Yong-Qiang Yu
Journal:  Front Neurol       Date:  2022-02-02       Impact factor: 4.003

3.  Machine learning prediction of hematoma expansion in acute intracerebral hemorrhage.

Authors:  Satoru Tanioka; Tetsushi Yago; Katsuhiro Tanaka; Fujimaro Ishida; Tomoyuki Kishimoto; Kazuhiko Tsuda; Munenari Ikezawa; Tomohiro Araki; Yoichi Miura; Hidenori Suzuki
Journal:  Sci Rep       Date:  2022-07-21       Impact factor: 4.996

4.  Hematoma Expansion in Intracerebral Hemorrhage With Unclear Onset.

Authors:  Andrea Morotti; Gregoire Boulouis; Andreas Charidimou; Qi Li; Loris Poli; Paolo Costa; Valeria De Giuli; Eleonora Leuci; Federico Mazzacane; Giorgio Busto; Francesco Arba; Laura Brancaleoni; Sebastiano Giacomozzi; Luigi Simonetti; Michele Laudisi; Giuseppe Micieli; Anna Cavallini; Elisa Candeloro; Massimo Gamba; Mauro Magoni; Andrew D Warren; Christopher D Anderson; M Edip Gurol; Alessandro Biffi; Anand Viswanathan; Ilaria Casetta; Enrico Fainardi; Andrea Zini; Alessandro Pezzini; Alessandro Padovani; Steven M Greenberg; Jonathan Rosand; Joshua N Goldstein
Journal:  Neurology       Date:  2021-04-01       Impact factor: 9.910

5.  Quantitative CT radiomics-based models for prediction of haematoma expansion and poor functional outcome in primary intracerebral haemorrhage.

Authors:  Stefan Pszczolkowski; José P Manzano-Patrón; Zhe K Law; Kailash Krishnan; Azlinawati Ali; Philip M Bath; Nikola Sprigg; Rob A Dineen
Journal:  Eur Radiol       Date:  2021-04-16       Impact factor: 5.315

6.  Increased Prognostic Yield by Combined Assessment of Non-Contrast Computed Tomography Markers of Antithrombotic-Related Spontaneous Intracerebral Hemorrhage Expansion.

Authors:  Aristeidis H Katsanos; Himanshu Gupta; Andrea Morotti; Simon Beshara; Tushar Patil; Saeed Al-Zahrani; Georgios Tsivgoulis; Dariush Dowlatshahi; Joshua N Goldstein; Andreas Charidimou; Ashkan Shoamanesh
Journal:  J Clin Med       Date:  2022-03-14       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.